Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1983 3
1984 1
1991 1
1992 1
1993 2
1994 1
1995 1
1996 3
1997 6
1998 3
1999 8
2000 4
2001 7
2002 14
2003 13
2004 8
2005 17
2006 6
2007 16
2008 13
2009 10
2010 19
2011 19
2012 22
2013 20
2014 21
2015 20
2016 21
2017 23
2018 16
2019 19
2020 21
2021 30
2022 20
2023 19
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Results by year

Filters applied: . Clear all
Page 1
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial.
Planquette B, Bertoletti L, Charles-Nelson A, Laporte S, Grange C, Mahé I, Pernod G, Elias A, Couturaud F, Falvo N, Sevestre MA, Ray V, Burnod A, Brebion N, Roy PM, Timar-David M, Aquilanti S, Constans J, Bura-Rivière A, Brisot D, Chatellier G, Sanchez O, Meyer G, Girard P, Mismetti P; CASTA DIVA Trial Investigators. Planquette B, et al. Among authors: laporte s. Chest. 2022 Mar;161(3):781-790. doi: 10.1016/j.chest.2021.09.037. Epub 2021 Oct 8. Chest. 2022. PMID: 34627853 Clinical Trial.
[Editorial].
Laporte S, Chauvin F, Bourmaud A, Presles E. Laporte S, et al. Rev Epidemiol Sante Publique. 2017 May;65 Suppl 2:S45-S46. doi: 10.1016/j.respe.2017.03.002. Epub 2017 Mar 31. Rev Epidemiol Sante Publique. 2017. PMID: 28372835 French. No abstract available.
Platform trials.
Roustit M, Demarcq O, Laporte S, Barthélémy P, Chassany O, Cucherat M, Demotes J, Diebolt V, Espérou H, Fouret C, Galaup A, Gambotti L, Gourio C, Guérin A, Labruyère C, Paoletti X, Porcher R, Simon T, Varoqueaux N. Roustit M, et al. Among authors: laporte s. Therapie. 2023 Jan-Feb;78(1):29-38. doi: 10.1016/j.therap.2022.12.003. Epub 2022 Dec 5. Therapie. 2023. PMID: 36529559 Free PMC article.
Les essais plateformes.
Roustit M, Demarcq O, Laporte S, Barthélémy P, Chassany O, Cucherat M, Demotes J, Diebolt V, Espérou H, Fouret C, Galaup A, Gambotti L, Gourio C, Guérin A, Labruyère C, Paoletti X, Porcher R, Simon T, Varoqueaux N. Roustit M, et al. Among authors: laporte s. Therapie. 2023 Jan-Feb;78(1):19-28. doi: 10.1016/j.therap.2022.11.011. Epub 2022 Dec 5. Therapie. 2023. PMID: 36581520 Free PMC article. French.
A Probody T Cell-Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity.
Boustany LM, LaPorte SL, Wong L, White C, Vinod V, Shen J, Yu W, Koditek D, Winter MB, Moore SJ, Mei L, Diep L, Huang Y, Liu S, Vasiljeva O, West J, Richardson J, Irving B, Belvin M, Kavanaugh WM. Boustany LM, et al. Among authors: laporte sl. Cancer Res. 2022 Nov 15;82(22):4288-4298. doi: 10.1158/0008-5472.CAN-21-2483. Cancer Res. 2022. PMID: 36112781 Free PMC article.
Comité de surveillance indépendant dans les essais cliniques : de la justification scientifique à l’organisation.
Locher C, Laporte S, Derambure P, Chassany O, Girault C, Avakiantz A, Bahans C, Deplanque D, Fustier P, Germe AF, Kassaï B, Lacoste L, Petitpain N, Roustit M, Simon T, Train C, Cucherat M. Locher C, et al. Among authors: laporte s. Therapie. 2024 Jan-Feb;79(1):99-110. doi: 10.1016/j.therap.2023.10.013. Epub 2023 Nov 3. Therapie. 2024. PMID: 37985309 French. No abstract available.
Des études mono-bras aux études de comparaison externe. Considérations méthodologiques et recommandations.
Cucherat M, Laporte S, Delaitre O, Behier JM; participants à la table ronde 'Recherche clinique' des Ateliers de Giens XXXV; d'Andon A, Binlich F, Bureau S, Cornu C, Fouret C, Hoog Labouret N, Laviolle B, Miadi-Fargier H, Paoletti X, Roustit M, Simon T, Varoqueaux N, Vicaut E, Westerloppe J. Cucherat M, et al. Among authors: laporte s. Therapie. 2020 Jan-Feb;75(1):13-19. doi: 10.1016/j.therap.2019.12.002. Epub 2019 Dec 13. Therapie. 2020. PMID: 32063401 Free article. French. No abstract available.
The oxytocin receptor.
Zingg HH, Laporte SA. Zingg HH, et al. Among authors: laporte sa. Trends Endocrinol Metab. 2003 Jul;14(5):222-7. doi: 10.1016/s1043-2760(03)00080-8. Trends Endocrinol Metab. 2003. PMID: 12826328 Review.
Utilisation des objets connectés en recherche clinique.
Dhainaut JF, Huot L, Bouchara Pomar V, Dubray C; les participants à la table ronde « Technologies de santé » des Ateliers de Giens XXXIII; Augé P, Barthélémy P, Belghiti J, Bureau S, Cassagnes J, Deblois S, Di Palma M, Dorsay G, Duchossoy L, Durand-Salmon F, Escudier T, Fiorini M, Franc S, Gelpi O, Laporte S, Lavallée E, Lethiec F, Meunier JP, Peyret O, Samalin L, Vicaut E; et contributeurs. Dhainaut JF, et al. Among authors: laporte s. Therapie. 2018 Feb;73(1):41-51. doi: 10.1016/j.therap.2017.11.002. Epub 2017 Dec 11. Therapie. 2018. PMID: 29395302 French. No abstract available.
378 results